These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12097398)

  • 1. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease.
    Henri S; Chevillard C; Mergani A; Paris P; Gaudart J; Camilla C; Dessein H; Montero F; Elwali NE; Saeed OK; Magzoub M; Dessein AJ
    J Immunol; 2002 Jul; 169(2):929-36. PubMed ID: 12097398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.
    Alves Oliveira LF; Moreno EC; Gazzinelli G; Martins-Filho OA; Silveira AM; Gazzinelli A; Malaquias LC; LoVerde P; Leite PM; Correa-Oliveira R
    Infect Immun; 2006 Feb; 74(2):1215-21. PubMed ID: 16428771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender.
    Booth M; Mwatha JK; Joseph S; Jones FM; Kadzo H; Ireri E; Kazibwe F; Kemijumbi J; Kariuki C; Kimani G; Ouma JH; Kabatereine NB; Vennervald BJ; Dunne DW
    J Immunol; 2004 Jan; 172(2):1295-303. PubMed ID: 14707108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immune responses of Schistosoma mansoni-infected mice with distinct chronic forms of the disease.
    Silva LM; Oliveira SA; Ribeiro-dos-Santos R; Andrade ZA; Soares MB
    Acta Trop; 2004 Jul; 91(2):189-96. PubMed ID: 15234668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine secretion profile associated with periportal fibrosis in S. mansoni-infected Egyptian patients.
    Talaat RM; El-Bassiouny AI; Osman AM; Yossif M; Charmy R; Al-Sherbiny MM
    Parasitol Res; 2007 Jul; 101(2):289-99. PubMed ID: 17323139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.
    Farah IO; Mola PW; Kariuki TM; Nyindo M; Blanton RE; King CL
    J Immunol; 2000 May; 164(10):5337-43. PubMed ID: 10799896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice.
    Cheever AW; Jankovic D; Yap GS; Kullberg MC; Sher A; Wynn TA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():25-32. PubMed ID: 9921320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
    Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene.
    Dessein AJ; Hillaire D; Elwali NE; Marquet S; Mohamed-Ali Q; Mirghani A; Henri S; Abdelhameed AA; Saeed OK; Magzoub MM; Abel L
    Am J Hum Genet; 1999 Sep; 65(3):709-21. PubMed ID: 10441577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human
    Franco KGS; de Amorim FJR; Santos MA; Rollemberg CVV; de Oliveira FA; França AVC; Santos CNO; Magalhães LS; Cazzaniga RA; de Lima FS; Benevides L; Carregaro V; Silva JS; Brito HLF; Fernandes DA; da Silva ÂM; de Almeida RP; Bezerra-Santos M; de Jesus AR
    Front Immunol; 2021; 12():779534. PubMed ID: 34970264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunological consequences of human T cell leukemia virus type-I and Schistosoma mansoni co-infection.
    Santos SB; Porto AF; Muniz AL; Jesus AR; Carvalho EM
    Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):121-6. PubMed ID: 15486648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity.
    Doehring-Schwerdtfeger E; Abdel-Rahim IM; Mohamed-Ali Q; Elsheikh M; Schlake J; Kardorff R; Franke D; Kaiser C; Ehrich JH
    Am J Trop Med Hyg; 1990 Jun; 42(6):581-6. PubMed ID: 2115307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ.
    Ramalingam TR; Gieseck RL; Acciani TH; M Hart K; Cheever AW; Mentink-Kane MM; Vannella KM; Wynn TA
    J Pathol; 2016 Jul; 239(3):344-54. PubMed ID: 27125685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni).
    Chevillard C; Moukoko CE; Elwali NE; Bream JH; Kouriba B; Argiro L; Rahoud S; Mergani A; Henri S; Gaudart J; Mohamed-Ali Q; Young HA; Dessein AJ
    J Immunol; 2003 Nov; 171(10):5596-601. PubMed ID: 14607968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL-4 and IFN-gamma in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function.
    Chensue SW; Terebuh PD; Warmington KS; Hershey SD; Evanoff HL; Kunkel SL; Higashi GI
    J Immunol; 1992 Feb; 148(3):900-6. PubMed ID: 1309844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies.
    Asseman C; Pancré V; Quatennens B; Auriault C
    Immunol Lett; 1996 Dec; 54(1):11-20. PubMed ID: 9030976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12.
    Hoffmann KF; Caspar P; Cheever AW; Wynn TA
    J Immunol; 1998 Oct; 161(8):4201-10. PubMed ID: 9780194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-regulatory role of interferon-gamma (IFN-gamma), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation.
    Chensue SW; Warmington KS; Ruth J; Lincoln PM; Kunkel SL
    Clin Exp Immunol; 1994 Dec; 98(3):395-400. PubMed ID: 7994903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.